Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication
May 29, 2024 08:30 ET
|
Cytosurge AG
CellEDIT uses FluidFM for precise nuclear CRISPR/Cas9 injection, boosting efficiency by controlling RNP amounts, preserving traits in edited CHO-K1 cells.
Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication
May 29, 2024 02:30 ET
|
Cytosurge AG
CellEDIT uses FluidFM for precise nuclear CRISPR/Cas9 injection, boosting efficiency by controlling RNP amounts, preserving traits in edited CHO-K1 cells.
Synthego Introduces First CRISPR Guaranteed Editing Genome Engineering Solution
December 14, 2017 09:02 ET
|
Synthego
REDWOOD CITY, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Synthego, a leading provider of genome engineering solutions, announces the launch of its new CRISPRevolution™ Gene Knockout Kit (GKO) with...